Loading...

People

Loading...

Charles P. Quesenberry, Jr., PhD

Charles P. Quesenberry, Jr., PhDKaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3752 (phone)
charles.quesenberry@kp.org

Charles P. Quesenberry, PhD, is a biostatistician and research scientist at the Kaiser Permanente Northern California Division of Research. He obtained his doctorate in biostatistics at the University of California, Berkeley, and has worked at the Division of Research since 1986. Dr. Quesenberry has been primarily involved with epidemiologic, statistical methods, and health services research projects relating to HIV/AIDS, hepatitis, obesity, health effects of air pollution, diabetes, cardiovascular disease, and cancer of the lung, breast, colon/rectum, and prostate. He is currently an associate editor for Hepatology and is director of the Northern California Kaiser Permanente Cancer Registry.

Current Position(s):

  • Biostatistician III, Division of Research, Kaiser Permanente Northern California

Primary Research Interests:

  • Lung cancer
  • Obesity
  • Survival analysis
  • Cost of disease
  • Infectious disease including HIV/AIDS and viral hepatitis

Related Web sites

Loading...

Risk of Cancer in Patients Exposed to Buproprion

This multi-site nested case-control study compares risk of cancer (prostate, breast, lung, colon/rectum, bladder, uterus) in users of buproprion to that in users of other antidepressants. 
Funder: GlaxoSmithKline
Principal Investigator: Quesenberry, Charles

Loading...

Genetic and Molecular Epidemiology of Adult Glioma (Glioma)

This project aims to enhance the understanding of how demographic, environmental, and immunological factors influence glioma susceptibility and prognosis and how different constellations of factors may be involved with different histologic and molecular subtypes of glioma. 
Funder: National Cancer Institute
Principal Investigator: Quesenberry, Charles

Loading...

Better Asthma Outcomes: Lowering Tobacco Smoke Exposure

This project tests the hypothesis that an ETS intervention will be associated with decreased asthma crisis care utilization, lower ETS exposure and improvements in secondary disease outcomes at follow-up when compared with usual medical care. 
Funder: National Heart, Lung, and Blood Institute
Principal Investigator: Quesenberry, Charles

Loading...

Biomarkers of Lung Cancer Susceptibility in Minorities

This study focuses on African-Americans who bear a disproportionate burden of lung cancer and Latinos who have very low rates.
Funder: Nat. Inst. of Environmental Health Sciences
Principal Investigator: Quesenberry, Charles